ANTI-TSH RECEPTOR ANTIBODY (TRAb) - NEONATAL SCREENING - ANVISA Registration 80254180473
Access comprehensive regulatory information for ANTI-TSH RECEPTOR ANTIBODY (TRAb) - NEONATAL SCREENING in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80254180473 and manufactured by manufacturer not specified. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until Feb 10, 2035.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 1 companies making the same product including SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD., and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
80254180473
25351412106202489
04930429000139
Company Information
Dates and Status
Feb 10, 2025
10/02/2035
09/18/2025 19:00:01
ANTICORPO ANTI-RECEPTOR DE TSH (TRAb) - TRIAGEM NEONATAL
Famรญlia MAGLUMI TRAb (CLIA)
Not specified
80102512963
Feb 22, 2023
ANTICORPO ANTI-RECEPTOR DE TSH (TRAb) - TRIAGEM NEONATAL
Famรญlia MAGLUMI TRAb (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102512963
Feb 22, 2023
ANTICORPO ANTI-RECEPTOR DE TSH (TRAb) - TRIAGEM NEONATAL
MAGLUMI TRAb (CLIA)
Not specified
80102511795
Jun 12, 2017
ANTICORPO ANTI-RECEPTOR DE TSH (TRAb) - TRIAGEM NEONATAL
MAGLUMI TRAb (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102511795
Jun 12, 2017

